ATTACKING BRAIN TUMORS HEAD-ON.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Karpa, Kelly Dowhower
المصدر:
Drug Topics. 9/18/2006, Vol. 150 Issue 18, special section p9-12. 3p. 3 Color Photographs, 1 Diagram.

معلومة اضافية
- الموضوع:
  BRAIN tumors; GLIOBLASTOMA multiforme; DRUGS; ANTINEOPLASTIC agents; THERAPEUTICS; CLINICAL trials; MONOCLONAL antibodies; INTERLEUKIN-13; EPIDERMAL growth factor; GRANULOCYTE-macrophage colony-stimulating factor
- نبذة مختصرة :
  The article explains that 34 drugs are in clinical trials for the treatment of glioblastoma multiforme and brain tumors, which means pharmacists will be playing an expanded role in the treatment of these diseases. A monoclonal antibody called bevacizumab inhibits the activity of vascular endothelial growth factor and disrupts a tumor's blood supply. Antineoplastic agents on trial include irinotecan, temozolamide, epidermal growth factor receptor variant III, granulocyte macrophage colony stimulating factor, interleukin-13 receptors, and cintredekin besudotox. INSET: Help for caregivers..